That's added value, on top of current MC... REVO announced today that it signed a multi-year definitive worldwide licensing agreement with a company for them to commercialize REVO's patented "EyeTalk Communicator System". The Licensee will pay REVO an up-front or pre-commercialization fee of $900,000 in consideration, and the Licensee has plans to commercialize and exploit the patents in the marketplace for the maximum financial benefit for both companies.
Of the $20 to $30 million in total estimated annual revenues projected to be generated from the marketing and exploitation of the patents, the Licensee would receive 60% and REVO would receive an estimated 40% of the total, or $8 to $12 million annually.
REVO's Senior Vice President Solomon Ali says, "We feel very positive about the new partnership with our Licensee and the potential revenues. The total forecasted annual revenues to be generated is in the $20 to $30 million range. The potential earnings for REVO is estimated at $8 to $12 million annually. Although we cannot guarantee an actual valuation, according to industry valuation standards using average P/E ratios from Standard & Poor's, at a multiple of 15 times earnings, a valuation of $120 to $180 million dollars is an estimate of the potential additional market value of the earnings to REVO." http://ih.advfn.com/p.php?pid=nmona&article=61038584
News 
Market Data 
Discover 
AI
